SciVision Biotech Inc. (1786.TW)

TWD 90.3

(-1.85%)

Revenue Summary of SciVision Biotech Inc.

  • SciVision Biotech Inc.'s latest annual revenue in 2023 was 712.98 Million TWD , up 27.93% from previous year.
  • SciVision Biotech Inc.'s latest quarterly revenue in 2024 Q2 was 210.55 Million TWD , up 7.78% from previous quarter.
  • SciVision Biotech Inc. reported a annual revenue of 557.34 Million TWD in annual revenue 2022, up 10.25% from previous year.
  • SciVision Biotech Inc. reported a annual revenue of 505.53 Million TWD in annual revenue 2021, up 8.28% from previous year.
  • SciVision Biotech Inc. reported a quarterly revenue of 210.55 Million TWD for 2024 Q2, up 7.78% from previous quarter.
  • SciVision Biotech Inc. reported a quarterly revenue of 120.37 Million TWD for 2023 Q1, down -24.7% from previous quarter.

Annual Revenue Chart of SciVision Biotech Inc. (2023 - 2009)

Historical Annual Revenue of SciVision Biotech Inc. (2023 - 2009)

Year Revenue Revenue Growth
2023 712.98 Million TWD 27.93%
2022 557.34 Million TWD 10.25%
2021 505.53 Million TWD 8.28%
2020 466.88 Million TWD 6.62%
2019 437.87 Million TWD 32.86%
2018 329.58 Million TWD 27.54%
2017 258.41 Million TWD 13.19%
2016 228.3 Million TWD -13.8%
2015 264.84 Million TWD 67.32%
2014 158.28 Million TWD -21.06%
2013 200.5 Million TWD -0.09%
2012 200.68 Million TWD 40.07%
2011 143.27 Million TWD 116.37%
2010 66.21 Million TWD 322.24%
2009 15.68 Million TWD 0.0%

Peer Revenue Comparison of SciVision Biotech Inc.

Name Revenue Revenue Difference
Nang Kuang Pharmaceutical Co., Ltd. 2.15 Billion TWD 66.841%
Maxigen Biotech Inc. 622.11 Million TWD -14.607%
Bionime Corporation 1.75 Billion TWD 59.387%
Pegavision Corporation 6.78 Billion TWD 89.499%
Visco Vision Inc. 2.39 Billion TWD 70.263%